Cardinal Health CAH Cost of product sold — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cardinal Health in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cardinal Health's cost of product sold — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cardinal Health's cost of product sold — total costs & expenses?
- Cardinal Health (CAH) reported cost of product sold — total costs & expenses of $3.12B in Q1 2026.
- How has Cardinal Health's cost of product sold — total costs & expenses changed year-over-year?
- Cardinal Health's cost of product sold — total costs & expenses increased by 0.1% year-over-year, from $3.12B to $3.12B.
- What is the long-term trend for Cardinal Health's cost of product sold — total costs & expenses?
- Over 2 years (2023 to 2025), Cardinal Health's cost of product sold — total costs & expenses has grown at a 0.5% compound annual growth rate (CAGR), from $12.37B to $12.5B.
- What does cost of product sold — total costs & expenses mean?
- This metric aggregates all costs and expenses associated with the cost of product sold segment, including direct product costs and operating overhead. It represents the total expenditure required to maintain the segment's operations.